This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Coronary Artery Disease Heart Failure Outcomes 
European Journal of Heart Failure
MARCH 10, 2025
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heart failure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure.
Cardiovascular Diabetology
AUGUST 6, 2024
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry. vs. 10.5%) and chronic kidney disease (3.7%
Frontiers in Cardiovascular Medicine
APRIL 1, 2025
IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients. The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP).
52 
Frontiers in Cardiovascular Medicine
OCTOBER 7, 2024
ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.
DAIC
MAY 2, 2024
About Chronic Myocardial Ischemia with Refractory Angina Chronic myocardial ischemia occurs in the setting of coronary artery disease when there is reduced blood flow to the heart. million patients in the United States. CAUTION - Limited by United States law to investigational use.
95 
MIBHS
JANUARY 15, 2025
Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Reduced Long-Term Success Rates For smokers, the long-term success of heart surgeries is often diminished.
DAIC
JANUARY 15, 2024
Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.
119 
European Journal of Heart Failure
SEPTEMBER 26, 2023
Abstract Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. Use of this acronym would enable the early diagnosis of heart failure.
DAIC
APRIL 9, 2024
Decline in exercise ability is a hallmark of progression to overt heart failure. These results also speak to the importance of continuing to focus on earlier recognition of heart failure risk in patients with diabetes and on initiating treatment before the condition has progressed to overt heart failure.”
DAIC
JUNE 4, 2024
fold higher risk for major adverse cardiac events (MACE) Caristo's AI-Risk model, CaRi-Heart Risk Score, outperformed other scores in routine clinical use for prediction of cardiac mortality, and when presented to clinicians, resulted in changes of management decision in 45% of the patients. fold higher risk for cardiac mortality and 5.5-fold
116 
DAIC
APRIL 3, 2024
Featured topics will include in-depth sessions covering non-statin lipid lowering therapies, heart failure with preserved ejection fraction, viability, imaging modalities for the assessment of coronary artery disease, and antiplatelet therapy after coronary stenting. Too Many Choices?
105 
All About Cardiovascular System and Disorders
MAY 26, 2024
It is now well known that even if a coronary artery is opened well after a myocardial infarction, with good flow in the epicardial coronary arteries, there could be impaired myocardial perfusion. In the initial era of primary PCI, angiographic myocardial blush was taken as a surrogate of effective myocardial reperfusion.
52 
AMS Cardiology
MARCH 31, 2025
Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options.
Journal of the American Heart Association
MARCH 27, 2025
The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.
Coronary Artery Disease Journal
JUNE 2, 2024
Aim The aim of this study was to determine the best clinical predictors of acute heart failure needing mechanical ventilation (MV) in the first 48 h of evolution of patients admitted because of acute coronary syndrome (ACS). Methods We analyzed a cohort of patients admitted for ACS between February 2017 and February 2018.
American College of Cardiology
FEBRUARY 1, 2025
Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement from the American Heart Association. BMC Med2015;13(74). Circulation. Circulation.
Stroke Journal
JANUARY 30, 2025
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. The prevalences of all vascular outcomes are summarized in Table 1. p < 001).
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. We performed this retrospective cohort analysis to assess the impact of poorly controlled diabetes, defined as HbA1C of 9.0% or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
40 
European Journal of Heart Failure
SEPTEMBER 15, 2023
Aims Patients with heart failure usually have several other medical conditions that might alter the effects of interventions. A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n = 920), coronary artery disease ( n = 3732), diabetes ( n = 2171), and hypertension ( n = 3353).
Journal of the American Heart Association
DECEMBER 12, 2023
Similar methods could be applied to identify the source and magnitude of variation in other health care processes and outcomes. Our results raise concern that payment models may influence cardiac imaging practice.
45 
Stroke Journal
FEBRUARY 1, 2024
We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32
40 Stroke Journal
FEBRUARY 1, 2024
Introduction:Mechanical Thrombectomy improves outcomes in patients with acute ischemic stroke due to large vessel occlusion. Records were reviewed for the study outcome which was recurrent ischemic stroke during the in-hospital period, defined as new or worsening neurological symptoms due to new infarct or extension of the infarct.
40 
Stroke Journal
FEBRUARY 1, 2024
Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Introduction:A rising prevalence of stroke in young patients was noticed in recent years. were male, and 60.4%
40 
Society of Thoracic Surgeons - Congenital
MARCH 17, 2025
This 3-day event will bring together a world-class, international faculty to explore the latest developments and best practices in coronary artery disease, congenital heart disease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure.
GEMMS
AUGUST 29, 2024
These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.
52 
EMS 12-Lead
MARCH 19, 2023
He denied any known medical history, specifically: coronary artery disease, hypertension, dyslipidemia, diabetes, heart failure, myocardial infarction, or any prior PCI/stent. Vital signs were noted to be unremarkable with respect to any hypo-hypertensive crisis, hypoxia, etc. No appreciable skin pallor.
Cardiology Update
MARCH 5, 2024
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. years, with 57.1% occurring within 30 days after CABG. years, with 21.1% occurring within 30 days after PCI.
Journal of the American Heart Association
JANUARY 23, 2025
BackgroundAcute psychological stress may induce physiological changes predisposing individuals to adverse health outcomes through hemodynamic and vascular effects. The outcome was a composite of cardiovascular death, nonfatal myocardial infarction, and heart failure hospitalizations during followup.
Journal of the American Heart Association
FEBRUARY 26, 2025
However, the role of body composition, including body fat percentage and lean body mass (LBM), in cardiovascular outcomes has not been well studied in patients with coronary artery disease (CAD). Future research studying the implications of changes in body composition on outcomes in men and women with CAD is warranted.
Circulation: Cardiovascular Quality & Outcomes
NOVEMBER 20, 2024
Circulation: Cardiovascular Quality and Outcomes, Volume 17, Issue 12 , Page e011040, December 1, 2024. BACKGROUND:Posttraumatic stress disorder (PTSD) is associated with maladaptive dysregulation of stress response systems, which could lead to an increased risk of heart failure. 95% CI, 2.67.3). 95% CI, 2.16.3]).
MIBHS
MARCH 31, 2025
Visiting the emergency room at the first sign of a heart attack can help begin treatment quickly and prevent complications like heart failure. Conclusion Although heart attack and cardiac arrest are often used interchangeably, they are separate conditions with different causes and treatments.
European Journal of Heart Failure
OCTOBER 5, 2023
In this study, two independent cohorts were used to investigate for cardiovascular magnetic resonance (CMR) and genetic features of dilated cardiomyopathy (DCM) in individuals with coronary artery disease (CAD). NI-LGE was not independently associated with adverse clinical outcomes. vs. 6.7%, odds ratio 1.5,
European Journal of Heart Failure
MARCH 30, 2025
AHF, acute heart failure; CABG, coronary artery bypass graft; CI, confidence interval; CV, cardiovascular; GDMT, guideline-directed medical therapy; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; OR, odds ratio; PCI, percutaneous coronary intervention.
Circulation: Cardiovascular Quality & Outcomes
APRIL 29, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Ischemic cardiomyopathy is the leading cause of heart failure (HF). Most patients do not undergo coronary assessment after HF diagnosis. Women, older individuals, and people without stable housing were less likely to complete coronary assessment.
Coronary Artery Disease Journal
JUNE 30, 2024
Background This study investigated the relationship between coronary artery disease–reporting and data system (CAD-RADS) for coronary computed tomography angiogram (CCTA) and major adverse cardiovascular and cerebral event (MACE) in a symptomatic Southeast Asian, Thai population over a 5-year period.
Journal of the American Heart Association
DECEMBER 8, 2023
Journal of the American Heart Association, Ahead of Print. BackgroundLiterature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronary artery disease (CAD). They were more likely to experience the following adverse outcomes: all‐cause death (adjusted hazard ratio [HR], 1.57 ([95% CI, 1.29–1.92];P<0.001)
Circulation
NOVEMBER 6, 2023
Background:Randomized trials in obstructive coronary artery disease (CAD) have largely shown no prognostic benefit from coronary revascularization. We identified the presence and cause of cardiomyopathy using CMR and coronary angiography data, blinded to clinical outcomes. Circulation, Ahead of Print.
DAIC
JUNE 12, 2024
The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds.
105 
European Journal of Heart Failure
DECEMBER 22, 2023
ABSTRACT Aims The aim of this analysis was to provide data on the overall comorbidity burden, both cardiovascular (CV) and non-CV, in a large real-world heart failure (HF) population across the ejection fraction (EF). All comorbidities, except for coronary artery disease (CAD), were more frequent in HF with preserved EF (HFpEF).
Journal of the American Heart Association
MARCH 4, 2025
An increasing number of studies have shown the impact of social determinants of health (SDoHs) on different cardiovascular outcomes. In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.
Cardiometabolic Health Congress
JULY 25, 2023
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?
52 
Frontiers in Cardiovascular Medicine
FEBRUARY 11, 2025
IntroductionDespite growing evidence for sex-specific differences in cardiovascular disease, sex is poorly considered in the management of infectious endocarditis (IE).PurposeThis IE was diagnosed using the Duke criteria.
52 
All About Cardiovascular System and Disorders
OCTOBER 25, 2023
AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heart failure and in those with associated cardiovascular conditions and early AF.
Circulation
NOVEMBER 11, 2024
We aimed to investigate the impact of albumin levels and their changes on clinical outcomes among patients who were admitted to intensive care units due to cardiac causes.Methods:This is a retrospective, single-center, cohort study. Consecutive patients admitted to coronary care unit (CCU) were enrolled between January 2011 and December 2020.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content